SK Biopharmaceuticals Statistics

Total Valuation

KRX:326030 has a market cap or net worth of KRW 7.08 trillion. The enterprise value is 6.97 trillion.

Market Cap	7.08T
Enterprise Value	6.97T

Important Dates

The last earnings date was Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

KRX:326030 has 78.31 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	78.31M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	12.98%
Float	28.06M

Valuation Ratios

The trailing PE ratio is 29.41 and the forward PE ratio is 39.75.

PE Ratio	29.41
Forward PE	39.75
PS Ratio	12.93
PB Ratio	12.33
P/TBV Ratio	13.22
P/FCF Ratio	75.71
P/OCF Ratio	74.60
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 84.44, with an EV/FCF ratio of 74.51.

EV / Earnings	28.94
EV / Sales	12.72
EV / EBITDA	84.44
EV / EBIT	107.05
EV / FCF	74.51

Financial Position

The company has a current ratio of 1.64, with a Debt / Equity ratio of 0.32.

Current Ratio	1.64
Quick Ratio	1.26
Debt / Equity	0.32
Debt / EBITDA	1.62
Debt / FCF	1.97
Interest Coverage	9.02

Financial Efficiency

Return on equity (ROE) is 50.72% and return on invested capital (ROIC) is 9.58%.

Return on Equity (ROE)	50.72%
Return on Assets (ROA)	6.84%
Return on Invested Capital (ROIC)	9.58%
Return on Capital Employed (ROCE)	15.04%
Revenue Per Employee	2.27B
Profits Per Employee	998.91M
Employee Count	241
Asset Turnover	0.62
Inventory Turnover	0.40

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.39% in the last 52 weeks. The beta is 0.94, so KRX:326030's price volatility has been similar to the market average.

Beta (5Y)	0.94
52-Week Price Change	+9.39%
50-Day Moving Average	104,918.00
200-Day Moving Average	106,018.50
Relative Strength Index (RSI)	29.53
Average Volume (20 Days)	164,938

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:326030 had revenue of KRW 547.60 billion and earned 240.74 billion in profits. Earnings per share was 3,074.04.

Revenue	547.60B
Gross Profit	504.50B
Operating Income	96.34B
Pretax Income	72.60B
Net Income	240.74B
EBITDA	113.77B
EBIT	96.34B
Earnings Per Share (EPS)	3,074.04

Full Income Statement

Balance Sheet

The company has 324.49 billion in cash and 184.48 billion in debt, giving a net cash position of 140.01 billion or 1,787.78 per share.

Cash & Cash Equivalents	324.49B
Total Debt	184.48B
Net Cash	140.01B
Net Cash Per Share	1,787.78
Equity (Book Value)	573.98B
Book Value Per Share	6,975.49
Working Capital	255.10B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 94.90 billion and capital expenditures -1.40 billion, giving a free cash flow of 93.50 billion.

Operating Cash Flow	94.90B
Capital Expenditures	-1.40B
Free Cash Flow	93.50B
FCF Per Share	1,193.98

Full Cash Flow Statement

Margins

Gross margin is 92.13%, with operating and profit margins of 17.59% and 43.96%.

Gross Margin	92.13%
Operating Margin	17.59%
Pretax Margin	13.26%
Profit Margin	43.96%
EBITDA Margin	20.78%
EBIT Margin	17.59%
FCF Margin	17.08%

Dividends & Yields

KRX:326030 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	3.40%
FCF Yield	1.32%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KRX:326030 has an Altman Z-Score of 9.97.

Altman Z-Score	9.97
Piotroski F-Score	n/a